Table 1.
Clinical characteristics of patients.
| Total (n = 40) | Before KT (n = 18) | After KT (n = 22) | t value | p value | |
|---|---|---|---|---|---|
| Patient demographic | |||||
| Age (mean ± SD) | 39.75 ± 12.19 | 37.83 ± 10.11 | 41.32 ± 13.47 | 0.885 | 0.382 |
| Male, n (%) | 21 (52.50%) | 10 (55.56%) | 11 (50.00%) | — | 0.761 |
| BMI | 20.60 ± 3.42 | 20.46 ± 3.60 | 20.77 ± 3.42 | 0.290 | 0.773 |
| Insertion site of CVC | |||||
| Insertion with CVC | 40 (100.00%) | 18 (45.00%) | 22 (55%) | — | — |
| Internal jugular vein, n (%) | 34 (85.00%) | 12 (66.67%) | 22 (100.00%) | — | 0.005 |
| Femoral vein, n (%) | 6 (15.00%) | 6 (33.33%) | 0 (0.00%) | — | 0.005 |
| Duration of catheterization, days (mean ± SD) | 115.9 ± 157.42 | 91.83 ± 161.71 | 135.59 ± 151.00 | 0.861 | 0.395 |
| ISD use, n (%) | 22 (55.00%) | 0 (0.00%) | 22 (100.00%) | — | — |
| Duration from ISD use to catheter removal, days (mean ± SD) | 14.00 ± 14.35 | — | 14.00 ± 14.35 | — | — |
| Suspected infection, n (%) | 6 (15.00%) | 4 (22.22%) | 2 (9.09%) | — | 0.381 |
| Antibiotic use, n (%) | 26 (65.00%) | 4 (22.22%) | 22 (100.00%) | — | <0.001 |
| Days hospitalized, days (IQR) | 15 (3-59) | 7 (3-29) | 15.5 (13-59) | 3.063 | 0.004 |
| Laboratory parameters | |||||
| WBC, (3.5–9.5) ×10^9/L | 8.57 ± 3.94 | 7.06 ± 2.07 | 9.81 ± 4.63 | 2.273 | 0.029 |
| NEU, (1.8–6.3) ×10^9/L | 6.14 ± 3.20 | 4.75 ± 1.86 | 7.28 ± 3.60 | 2.633 | 0.012 |
| RBC, Male (4.3–5.8) ×10^9/L, Female (3.8–5.1) ×10^9/L | 3.61 ± 0.75 | 3.39 ± 0.71 | 3.80 ± 0.74 | 1.729 | 0.092 |
| PLT, (125–350) ×10^9/L | 215.23 ± 63.81 | 220.39 ± 67.20 | 211.00 ± 60.57 | 0.452 | 0.654 |
| HGB, Male (130–175) g/L, female (115–150) g/L | 103.15 ± 17.53 | 95 ± 17.92 | 109.82 ± 14.04 | 2.858 | 0.007 |
| CRP, (0–6) mg/L | 11.34 ± 21.66 | 16.08 ± 29.59 | 7.34 ± 9.62 | 1.179 | 0.247 |
| Scr, Male (57–97) μmol/L, female (41–81) μmol/L | 215.20 ± 134.95 | — | 215.20 ± 134.95 | — | — |
| DGF | 5 (12.50%) | — | 5 (22.73%) | — | — |
| Underlying diseases | |||||
| Diabetes mellitus, n (%) | 5 (12.50%) | 1 (5.56%) | 4 (18.18%) | — | 0.356 |
| Chronic hepatitis/liver cirrhosis, n (%) | 8 (20.00%) | 4 (22.22%) | 4 (18.18%) | — | 1.000 |
| Hypertension, n (%) | 30 (75.00%) | 15 (83.33%) | 15 (68.18%) | — | 0.465 |
*
KT: kidney transplantation; BMI: Body Mass Index; CVC: Central venous catheter; SD: standard deviation; ISD: immunosuppressive drugs; IQR: interquartile range; WBC: white blood cell; NEU: Neutrophils; WBC: red blood cell; PLT: platelet; HGB: hemoglobin; Scr: serum creatinine; CRP: C-reactive protein; DGF: delayed graft function.